Boldan, B.; Kunt, B.; Çamili, F.E.; Kunt, A.; Yiğit, A.; Güney, G.; İslimye Taşkın, M.; Turan, G.; Yörük, Y.E.; Afsar, S.
Endometrioid Immunohistochemical Prognostic Score Integrating SIRT1, HMGB1, Bcl-2, and Caspase-3 Expression in Endometrioid-Type Endometrial Cancer. Diagnostics 2026, 16, 2701.
https://doi.org/10.3390/diagnostics16172701
AMA Style
Boldan B, Kunt B, Çamili FE, Kunt A, Yiğit A, Güney G, İslimye Taşkın M, Turan G, Yörük YE, Afsar S.
Endometrioid Immunohistochemical Prognostic Score Integrating SIRT1, HMGB1, Bcl-2, and Caspase-3 Expression in Endometrioid-Type Endometrial Cancer. Diagnostics. 2026; 16(17):2701.
https://doi.org/10.3390/diagnostics16172701
Chicago/Turabian Style
Boldan, Birant, Batuhan Kunt, Figen Efe Çamili, Atilla Kunt, Abdurrahman Yiğit, Gürhan Güney, Mine İslimye Taşkın, Gülay Turan, Yunus Emre Yörük, and Selim Afsar.
2026. "Endometrioid Immunohistochemical Prognostic Score Integrating SIRT1, HMGB1, Bcl-2, and Caspase-3 Expression in Endometrioid-Type Endometrial Cancer" Diagnostics 16, no. 17: 2701.
https://doi.org/10.3390/diagnostics16172701
APA Style
Boldan, B., Kunt, B., Çamili, F. E., Kunt, A., Yiğit, A., Güney, G., İslimye Taşkın, M., Turan, G., Yörük, Y. E., & Afsar, S.
(2026). Endometrioid Immunohistochemical Prognostic Score Integrating SIRT1, HMGB1, Bcl-2, and Caspase-3 Expression in Endometrioid-Type Endometrial Cancer. Diagnostics, 16(17), 2701.
https://doi.org/10.3390/diagnostics16172701
